Annual report

Period2022-01-21 → 2023-01-20

Filed2023-04-17

StandardJapan GAAP

ConsolidatedYes

Data checks24 of 24 passed

Key figures · 148

Metric	Value	Period	Scope	Source row
Revenue	¥160.1bn	2022-01-21 → 2023-01-20	Cons.	Net sales
Revenue	¥162.6bn	2021-01-21 → 2022-01-20	Cons.	Net sales
Revenue	¥158.2bn	2020-01-21 → 2021-01-20^d	Cons.	Net sales (5-year summary)
Revenue	¥168.3bn	2019-01-21 → 2020-01-20^d	Cons.	Net sales (5-year summary)
Revenue	¥171.6bn	2018-01-21 → 2019-01-20^d	Cons.	Net sales (5-year summary)
Operating income	¥707m	2022-01-21 → 2023-01-20	Cons.	Operating income
Operating income	¥4.6bn	2021-01-21 → 2022-01-20	Cons.	Operating income
Ordinary income	¥591m	2022-01-21 → 2023-01-20	Cons.	Ordinary income
Ordinary income	¥5.7bn	2021-01-21 → 2022-01-20	Cons.	Ordinary income
Ordinary income	¥5.7bn	2020-01-21 → 2021-01-20^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥2.9bn	2019-01-21 → 2020-01-20^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥6.0bn	2018-01-21 → 2019-01-20^d	Cons.	Ordinary income loss (5-year summary)
Profit before tax	¥1.1bn	2022-01-21 → 2023-01-20	Cons.	Income before income taxes
Profit before tax	¥5.7bn	2021-01-21 → 2022-01-20	Cons.	Income before income taxes
Net income (owners)	−¥507m	2022-01-21 → 2023-01-20	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥4.0bn	2021-01-21 → 2022-01-20	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥3.2bn	2020-01-21 → 2021-01-20^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥1.8bn	2019-01-21 → 2020-01-20^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥3.9bn	2018-01-21 → 2019-01-20^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income	−¥490m	2022-01-21 → 2023-01-20	Cons.	Profit loss
Net income	¥3.9bn	2021-01-21 → 2022-01-20	Cons.	Profit loss
Total assets	¥164.2bn	at 2023-01-20	Cons.	Assets
Total assets	¥159.0bn	at 2022-01-20	Cons.	Assets
Total assets	¥157.6bn	at 2021-01-20^d	Cons.	Total assets (5-year summary)
Total assets	¥163.4bn	at 2020-01-20^d	Cons.	Total assets (5-year summary)
Total assets	¥171.6bn	at 2019-01-20^d	Cons.	Total assets (5-year summary)
Total liabilities	¥80.1bn	at 2023-01-20	Cons.	Liabilities
Total liabilities	¥75.7bn	at 2022-01-20	Cons.	Liabilities
Net assets / equity	¥84.1bn	at 2023-01-20	Cons.	Net assets
Net assets / equity	¥83.3bn	at 2022-01-20	Cons.	Net assets
Net assets / equity	¥82.6bn	at 2021-01-20^d	Cons.	Net assets
Net assets / equity	¥89.2bn	at 2020-01-20^d	Cons.	Net assets (5-year summary)
Net assets / equity	¥93.9bn	at 2019-01-20^d	Cons.	Net assets (5-year summary)
Cash and deposits	¥27.2bn	at 2023-01-20	Cons.	Cash and deposits
Cash and deposits	¥27.6bn	at 2022-01-20	Cons.	Cash and deposits
Cash & equivalents	¥29.2bn	at 2023-01-20	Cons.	Cash and cash equivalents
Cash & equivalents	¥30.1bn	at 2022-01-20	Cons.	Cash and cash equivalents
Cash & equivalents	¥32.7bn	at 2021-01-20^d	Cons.	Cash and cash equivalents
Cash & equivalents	¥30.3bn	at 2020-01-20^d	Cons.	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥38.4bn	at 2019-01-20^d	Cons.	Cash and cash equivalents (5-year summary)
Operating cash flow	¥5.1bn	2022-01-21 → 2023-01-20	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥8.1bn	2021-01-21 → 2022-01-20	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥12.5bn	2020-01-21 → 2021-01-20^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥11.5bn	2019-01-21 → 2020-01-20^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥10.9bn	2018-01-21 → 2019-01-20^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Investing cash flow	−¥5.0bn	2022-01-21 → 2023-01-20	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥6.5bn	2021-01-21 → 2022-01-20	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥7.6bn	2020-01-21 → 2021-01-20^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥15.5bn	2019-01-21 → 2020-01-20^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥16.9bn	2018-01-21 → 2019-01-20^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Financing cash flow	−¥1.1bn	2022-01-21 → 2023-01-20	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥3.7bn	2021-01-21 → 2022-01-20	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥2.3bn	2020-01-21 → 2021-01-20^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥4.1bn	2019-01-21 → 2020-01-20^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥2.6bn	2018-01-21 → 2019-01-20^d	Cons.	Net cash provided by used in financing activities (5-year summary)
EPS (basic)	¥-32.4	2022-01-21 → 2023-01-20	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥254.2	2021-01-21 → 2022-01-20	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥201.31	2020-01-21 → 2021-01-20^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥108	2019-01-21 → 2020-01-20^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥234.15	2018-01-21 → 2019-01-20^d	Cons.	Basic earnings loss per share (5-year summary)
Net assets per share	¥5,327.58	at 2023-01-20	Cons.	Net assets per share (5-year summary)
Net assets per share	¥5,290.73	at 2022-01-20	Cons.	Net assets per share (5-year summary)
Net assets per share	¥5,224.46	at 2021-01-20^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥5,341.36	at 2020-01-20^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥5,628.56	at 2019-01-20^d	Cons.	Net assets per share (5-year summary)
Equity ratio	50.9%	at 2023-01-20	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	52.1%	at 2022-01-20	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	51.8%	at 2021-01-20^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	53.9%	at 2020-01-20^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	54.0%	at 2019-01-20^d	Cons.	Equity to asset ratio (5-year summary)
ROE	-0.6%	2022-01-21 → 2023-01-20	Cons.	Rate of return on equity (5-year summary)
ROE	4.8%	2021-01-21 → 2022-01-20	Cons.	Rate of return on equity (5-year summary)
ROE	3.8%	2020-01-21 → 2021-01-20^d	Cons.	Rate of return on equity (5-year summary)
ROE	2.0%	2019-01-21 → 2020-01-20^d	Cons.	Rate of return on equity (5-year summary)
ROE	4.2%	2018-01-21 → 2019-01-20^d	Cons.	Rate of return on equity (5-year summary)
Employees	4,122	at 2023-01-20	Cons.	Number of employees
Employees	4,029	at 2022-01-20	Cons.	Number of employees
Employees	3,922	at 2021-01-20^d	Cons.	Number of employees
Employees	4,160	at 2020-01-20^d	Cons.	Number of employees
Employees	3,912	at 2019-01-20^d	Cons.	Number of employees
Revenue	¥5.0bn	2022-01-21 → 2023-01-20	Standalone	Operating revenue1
Revenue	¥4.8bn	2021-01-21 → 2022-01-20	Standalone	Operating revenue1
Revenue	¥4.8bn	2020-01-21 → 2021-01-20^d	Standalone	Operating revenue1 (5-year summary)
Revenue	¥6.6bn	2019-01-21 → 2020-01-20^d	Standalone	Operating revenue1 (5-year summary)
Revenue	¥9.2bn	2018-01-21 → 2019-01-20^d	Standalone	Operating revenue1 (5-year summary)
Operating income	¥1.7bn	2022-01-21 → 2023-01-20	Standalone	Operating income
Operating income	¥1.8bn	2021-01-21 → 2022-01-20	Standalone	Operating income
Ordinary income	¥2.3bn	2022-01-21 → 2023-01-20	Standalone	Ordinary income
Ordinary income	¥2.4bn	2021-01-21 → 2022-01-20	Standalone	Ordinary income
Ordinary income	¥1.9bn	2020-01-21 → 2021-01-20^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥4.0bn	2019-01-21 → 2020-01-20^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥6.8bn	2018-01-21 → 2019-01-20^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	¥2.8bn	2022-01-21 → 2023-01-20	Standalone	Income before income taxes
Profit before tax	¥2.2bn	2021-01-21 → 2022-01-20	Standalone	Income before income taxes
Net income	¥1.9bn	2022-01-21 → 2023-01-20	Standalone	Profit loss
Net income	¥1.4bn	2021-01-21 → 2022-01-20	Standalone	Profit loss
Net income	¥899m	2020-01-21 → 2021-01-20^d	Standalone	Net income loss (5-year summary)
Net income	¥2.4bn	2019-01-21 → 2020-01-20^d	Standalone	Net income loss (5-year summary)
Net income	¥5.8bn	2018-01-21 → 2019-01-20^d	Standalone	Net income loss (5-year summary)
Total assets	¥122.7bn	at 2023-01-20	Standalone	Assets
Total assets	¥122.2bn	at 2022-01-20	Standalone	Assets
Total assets	¥116.8bn	at 2021-01-20^d	Standalone	Total assets (5-year summary)
Total assets	¥119.1bn	at 2020-01-20^d	Standalone	Total assets (5-year summary)
Total assets	¥118.4bn	at 2019-01-20^d	Standalone	Total assets (5-year summary)
Total liabilities	¥42.3bn	at 2023-01-20	Standalone	Liabilities
Total liabilities	¥42.1bn	at 2022-01-20	Standalone	Liabilities
Net assets / equity	¥80.5bn	at 2023-01-20	Standalone	Net assets
Net assets / equity	¥80.1bn	at 2022-01-20	Standalone	Net assets
Net assets / equity	¥78.5bn	at 2021-01-20^d	Standalone	Net assets
Net assets / equity	¥84.7bn	at 2020-01-20^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥86.3bn	at 2019-01-20^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥21.1bn	at 2023-01-20	Standalone	Cash and deposits
Cash and deposits	¥21.3bn	at 2022-01-20	Standalone	Cash and deposits
EPS (basic)	¥122.15	2022-01-21 → 2023-01-20	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥91.77	2021-01-21 → 2022-01-20	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥56.51	2020-01-21 → 2021-01-20^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥147.92	2019-01-21 → 2020-01-20^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥350.21	2018-01-21 → 2019-01-20^d	Standalone	Basic earnings loss per share (5-year summary)
Dividend per share	¥60	2022-01-21 → 2023-01-20	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2021-01-21 → 2022-01-20	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2020-01-21 → 2021-01-20^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2019-01-21 → 2020-01-20^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2018-01-21 → 2019-01-20^d	Standalone	Dividend paid per share (5-year summary)
Net assets per share	¥5,128.06	at 2023-01-20	Standalone	Net assets per share (5-year summary)
Net assets per share	¥5,118.19	at 2022-01-20	Standalone	Net assets per share (5-year summary)
Net assets per share	¥5,025.94	at 2021-01-20^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥5,141.6	at 2020-01-20^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥5,239.52	at 2019-01-20^d	Standalone	Net assets per share (5-year summary)
Equity ratio	65.6%	at 2023-01-20	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	65.6%	at 2022-01-20	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	67.2%	at 2021-01-20^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	71.1%	at 2020-01-20^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	72.9%	at 2019-01-20^d	Standalone	Equity to asset ratio (5-year summary)
ROE	2.4%	2022-01-21 → 2023-01-20	Standalone	Rate of return on equity (5-year summary)
ROE	1.8%	2021-01-21 → 2022-01-20	Standalone	Rate of return on equity (5-year summary)
ROE	1.1%	2020-01-21 → 2021-01-20^d	Standalone	Rate of return on equity (5-year summary)
ROE	2.8%	2019-01-21 → 2020-01-20^d	Standalone	Rate of return on equity (5-year summary)
ROE	7.0%	2018-01-21 → 2019-01-20^d	Standalone	Rate of return on equity (5-year summary)
Shares issued	16,568,000	at 2023-01-20	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2022-01-20	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2021-01-20^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2020-01-20^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2019-01-20^d	Standalone	Total number of issued shares (5-year summary)
Employees	26	at 2023-01-20	Standalone	Number of employees
Employees	23	at 2022-01-20	Standalone	Number of employees
Employees	19	at 2021-01-20^d	Standalone	Number of employees
Employees	21	at 2020-01-20^d	Standalone	Number of employees
Employees	26	at 2019-01-20^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 93

Segment	Item	Period	Value
Reconciling Itemsreconciling	capex	2022-01-21 → 2023-01-20	¥1.5bn
Reconciling Itemsreconciling	depreciation	2022-01-21 → 2023-01-20	¥373m
Reconciling Itemsreconciling	revenue	2022-01-21 → 2023-01-20	−¥636m
Reconciling Itemsreconciling	revenue intersegment	2022-01-21 → 2023-01-20	−¥636m
Reconciling Itemsreconciling	segment assets	at 2023-01-20	¥47.8bn
Reconciling Itemsreconciling	segment profit	2022-01-21 → 2023-01-20	−¥1.6bn
Domestic Beverage Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥8.3bn
Domestic Beverage Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥4.6bn
Domestic Beverage Businessreportable segment	employees	at 2023-01-20	2806 pure
Domestic Beverage Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥109.8bn
Domestic Beverage Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥109.7bn
Domestic Beverage Businessreportable segment	revenue intersegment	2022-01-21 → 2023-01-20	¥25m
Domestic Beverage Businessreportable segment	segment assets	at 2023-01-20	¥60.4bn
Domestic Beverage Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	¥2.8bn
Dy Do Pharmareportable segment	capex	2022-01-21 → 2023-01-20	¥1m
Dy Do Pharmareportable segment	depreciation	2022-01-21 → 2023-01-20	¥2m
Dy Do Pharmareportable segment	employees	at 2023-01-20	12 pure
Dy Do Pharmareportable segment	segment assets	at 2023-01-20	¥1.1bn
Dy Do Pharmareportable segment	segment profit	2022-01-21 → 2023-01-20	−¥499m
Food Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥877m
Food Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥848m
Food Businessreportable segment	employees	at 2023-01-20	254 pure
Food Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥19.6bn
Food Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥19.6bn
Food Businessreportable segment	revenue intersegment	2022-01-21 → 2023-01-20	¥8m
Food Businessreportable segment	segment assets	at 2023-01-20	¥21.8bn
Food Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	¥765m
International Beverage Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥522m
International Beverage Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥718m
International Beverage Businessreportable segment	employees	at 2023-01-20	706 pure
International Beverage Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥18.9bn
International Beverage Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥18.9bn
International Beverage Businessreportable segment	segment assets	at 2023-01-20	¥13.5bn
International Beverage Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	−¥1.1bn
Pharmaceutical Related Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥220m
Pharmaceutical Related Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥1.2bn
Pharmaceutical Related Businessreportable segment	employees	at 2023-01-20	318 pure
Pharmaceutical Related Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥12.5bn
Pharmaceutical Related Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥11.9bn
Pharmaceutical Related Businessreportable segment	revenue intersegment	2022-01-21 → 2023-01-20	¥601m
Pharmaceutical Related Businessreportable segment	segment assets	at 2023-01-20	¥19.7bn
Pharmaceutical Related Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	¥347m
—segment total	capex	2022-01-21 → 2023-01-20	¥9.9bn
—segment total	depreciation	2022-01-21 → 2023-01-20	¥7.4bn
—segment total	revenue	2022-01-21 → 2023-01-20	¥160.8bn
—segment total	revenue external	2022-01-21 → 2023-01-20	¥160.1bn
—segment total	revenue intersegment	2022-01-21 → 2023-01-20	¥636m
—segment total	segment assets	at 2023-01-20	¥116.4bn
—segment total	segment profit	2022-01-21 → 2023-01-20	¥2.3bn
Reconciling Itemsreconciling	capex	2021-01-21 → 2022-01-20	¥864m
Reconciling Itemsreconciling	depreciation	2021-01-21 → 2022-01-20	¥386m
Reconciling Itemsreconciling	revenue	2021-01-21 → 2022-01-20	−¥553m
Reconciling Itemsreconciling	revenue intersegment	2021-01-21 → 2022-01-20	−¥553m
Reconciling Itemsreconciling	segment assets	at 2022-01-20	¥50.5bn
Reconciling Itemsreconciling	segment profit	2021-01-21 → 2022-01-20	−¥1.5bn
Domestic Beverage Businessreportable segment	capex	2021-01-21 → 2022-01-20	¥7.4bn
Domestic Beverage Businessreportable segment	depreciation	2021-01-21 → 2022-01-20	¥4.0bn
Domestic Beverage Businessreportable segment	revenue	2021-01-21 → 2022-01-20	¥118.1bn
Domestic Beverage Businessreportable segment	revenue external	2021-01-21 → 2022-01-20	¥118.0bn
Domestic Beverage Businessreportable segment	revenue intersegment	2021-01-21 → 2022-01-20	¥40m
Domestic Beverage Businessreportable segment	segment assets	at 2022-01-20	¥57.8bn
Domestic Beverage Businessreportable segment	segment profit	2021-01-21 → 2022-01-20	¥6.3bn
Dy Do Pharmareportable segment	capex	2021-01-21 → 2022-01-20	¥6m
Dy Do Pharmareportable segment	depreciation	2021-01-21 → 2022-01-20	¥1m
Dy Do Pharmareportable segment	segment assets	at 2022-01-20	¥27m
Dy Do Pharmareportable segment	segment profit	2021-01-21 → 2022-01-20	−¥573m
Food Businessreportable segment	capex	2021-01-21 → 2022-01-20	¥755m
Food Businessreportable segment	depreciation	2021-01-21 → 2022-01-20	¥815m
Food Businessreportable segment	revenue	2021-01-21 → 2022-01-20	¥21.2bn
Food Businessreportable segment	revenue external	2021-01-21 → 2022-01-20	¥21.1bn
Food Businessreportable segment	revenue intersegment	2021-01-21 → 2022-01-20	¥17m
Food Businessreportable segment	segment assets	at 2022-01-20	¥20.6bn
Food Businessreportable segment	segment profit	2021-01-21 → 2022-01-20	¥959m
International Beverage Businessreportable segment	capex	2021-01-21 → 2022-01-20	¥995m
International Beverage Businessreportable segment	depreciation	2021-01-21 → 2022-01-20	¥496m
International Beverage Businessreportable segment	revenue	2021-01-21 → 2022-01-20	¥12.8bn
International Beverage Businessreportable segment	revenue external	2021-01-21 → 2022-01-20	¥12.8bn
International Beverage Businessreportable segment	segment assets	at 2022-01-20	¥9.6bn
International Beverage Businessreportable segment	segment profit	2021-01-21 → 2022-01-20	−¥528m
Pharmaceutical Related Businessreportable segment	capex	2021-01-21 → 2022-01-20	¥223m
Pharmaceutical Related Businessreportable segment	depreciation	2021-01-21 → 2022-01-20	¥1.2bn
Pharmaceutical Related Businessreportable segment	revenue	2021-01-21 → 2022-01-20	¥11.1bn
Pharmaceutical Related Businessreportable segment	revenue external	2021-01-21 → 2022-01-20	¥10.6bn
Pharmaceutical Related Businessreportable segment	revenue intersegment	2021-01-21 → 2022-01-20	¥494m
Pharmaceutical Related Businessreportable segment	segment assets	at 2022-01-20	¥20.4bn
Pharmaceutical Related Businessreportable segment	segment profit	2021-01-21 → 2022-01-20	−¥19m
—segment total	capex	2021-01-21 → 2022-01-20	¥9.4bn
—segment total	depreciation	2021-01-21 → 2022-01-20	¥6.5bn
—segment total	revenue	2021-01-21 → 2022-01-20	¥163.2bn
—segment total	revenue external	2021-01-21 → 2022-01-20	¥162.6bn
—segment total	revenue intersegment	2021-01-21 → 2022-01-20	¥553m
—segment total	segment assets	at 2022-01-20	¥108.5bn
—segment total	segment profit	2021-01-21 → 2022-01-20	¥6.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,730

Item	Context	Value
Number of shareholders foreign individual investors	CurrentYearInstant_OrdinaryShareMember	46
Number of shareholders individuals and others	CurrentYearInstant_OrdinaryShareMember	35472
Number of shareholders total	CurrentYearInstant_OrdinaryShareMember	35815
Number of shares held number of units national and local governments	CurrentYearInstant_OrdinaryShareMember	－
Number of shares held number of units financial institutions	CurrentYearInstant_OrdinaryShareMember	16694
Number of shares held number of units financial service providers	CurrentYearInstant_OrdinaryShareMember	2358
Number of shares held number of units other corporations	CurrentYearInstant_OrdinaryShareMember	64375
Number of shares held number of units foreign investors other than individuals	CurrentYearInstant_OrdinaryShareMember	6393
Number of shares held number of units foreign individual investors	CurrentYearInstant_OrdinaryShareMember	49
Number of shares held number of units individuals and others	CurrentYearInstant_OrdinaryShareMember	75669
Number of shares held number of units total	CurrentYearInstant_OrdinaryShareMember	165538
Number of shares held shares less than one unit	CurrentYearInstant_OrdinaryShareMember	14700
Percentage of shareholdings national and local governments	CurrentYearInstant_OrdinaryShareMember	－
Percentage of shareholdings financial institutions	CurrentYearInstant_OrdinaryShareMember	0.1008
Percentage of shareholdings financial service providers	CurrentYearInstant_OrdinaryShareMember	0.0142
Percentage of shareholdings other corporations	CurrentYearInstant_OrdinaryShareMember	0.3889
Percentage of shareholdings foreigners other than individuals	CurrentYearInstant_OrdinaryShareMember	0.0386
Percentage of shareholdings foreign individuals	CurrentYearInstant_OrdinaryShareMember	0.0003
Percentage of shareholdings individuals and others	CurrentYearInstant_OrdinaryShareMember	0.4571
Number of shares held	CurrentYearInstant_No1MajorShareholdersMember	2470000
Shareholding ratio	CurrentYearInstant_No1MajorShareholdersMember	0.1554
Number of shares held	CurrentYearInstant_No2MajorShareholdersMember	2011000
Shareholding ratio	CurrentYearInstant_No2MajorShareholdersMember	0.1265
Number of shares held	CurrentYearInstant_No3MajorShareholdersMember	1032000
Shareholding ratio	CurrentYearInstant_No3MajorShareholdersMember	0.0649
Number of shares held	CurrentYearInstant_No4MajorShareholdersMember	638000
Shareholding ratio	CurrentYearInstant_No4MajorShareholdersMember	0.0401
Number of shares held	CurrentYearInstant_No5MajorShareholdersMember	495000
Shareholding ratio	CurrentYearInstant_No5MajorShareholdersMember	0.0311
Number of shares held	CurrentYearInstant_No6MajorShareholdersMember	495000
Shareholding ratio	CurrentYearInstant_No6MajorShareholdersMember	0.0311
Number of shares held	CurrentYearInstant_No7MajorShareholdersMember	494000
Shareholding ratio	CurrentYearInstant_No7MajorShareholdersMember	0.0310
Number of shares held	CurrentYearInstant_No8MajorShareholdersMember	279000
Shareholding ratio	CurrentYearInstant_No8MajorShareholdersMember	0.0175
Number of shares held	CurrentYearInstant_No9MajorShareholdersMember	250000
Shareholding ratio	CurrentYearInstant_No9MajorShareholdersMember	0.0157
Number of shares held	CurrentYearInstant_No10MajorShareholdersMember	223000
Shareholding ratio	CurrentYearInstant_No10MajorShareholdersMember	0.0140
Number of shares held	CurrentYearInstant	8389000
Shareholding ratio	CurrentYearInstant	0.5278
Number of shares issued shares voting rights	CurrentYearInstant_SharesWithNoVotingRightsMember	－
Number of shares issued shares voting rights	CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember	－
Number of shares issued shares voting rights	CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember	－
Number of voting rights issued shares voting rights	CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember	－
Number of shares issued shares voting rights	CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember	675800
Number of shares issued shares voting rights	CurrentYearInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember	2000
Number of shares issued shares voting rights	CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember	15876000
Number of voting rights issued shares voting rights	CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember	158760
Number of shares issued shares voting rights	CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember	14700

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed

balance sheet identity	consolidated 2022-01-20	pass rounding
balance sheet identity	consolidated 2023-01-20	pass
balance sheet identity	non_consolidated 2022-01-20	pass rounding
balance sheet identity	non_consolidated 2023-01-20	pass
dei present		pass
period resolution		pass
statement vs summary · net assets	consolidated 2021-01-20	pass
statement vs summary · net assets	consolidated 2022-01-20	pass
statement vs summary · net assets	consolidated 2023-01-20	pass
statement vs summary · net assets	non_consolidated 2021-01-20	pass
statement vs summary · net assets	non_consolidated 2022-01-20	pass
statement vs summary · net assets	non_consolidated 2023-01-20	pass
statement vs summary · net income attributable to parent	consolidated 2021-01-21/2022-01-20	pass
statement vs summary · net income attributable to parent	consolidated 2022-01-21/2023-01-20	pass
statement vs summary · operating cash flow	consolidated 2021-01-21/2022-01-20	pass
statement vs summary · operating cash flow	consolidated 2022-01-21/2023-01-20	pass
statement vs summary · revenue	consolidated 2021-01-21/2022-01-20	pass
statement vs summary · revenue	consolidated 2022-01-21/2023-01-20	pass
statement vs summary · revenue	non_consolidated 2021-01-21/2022-01-20	pass
statement vs summary · revenue	non_consolidated 2022-01-21/2023-01-20	pass
statement vs summary · total assets	consolidated 2022-01-20	pass
statement vs summary · total assets	consolidated 2023-01-20	pass
statement vs summary · total assets	non_consolidated 2022-01-20	pass
statement vs summary · total assets	non_consolidated 2023-01-20	pass